Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
about
A Polymorphic Variant of AFAP-110 Enhances cSrc ActivityThe prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based studyAdvanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress.Systems ChronotherapeuticsSerum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study.The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.Novel diagnostic and prognostic methods for disc degeneration and low back painCytokine gene associations with self-report ratings of morning and evening fatigue in oncology patients and their family caregivers.Body composition, symptoms, and survival in advanced cancer patients referred to a phase I serviceI'm so tired: biological and genetic mechanisms of cancer-related fatigueThe role of cytokines in breast cancer development and progressionA study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer.Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.The Prescription Pattern of Chinese Herbal Products Containing Ginseng among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based StudySurvival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survivalTumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancer.Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression.Biomarkers: symptoms, survivorship, and quality of lifeInformative gene network for chemotherapy-induced peripheral neuropathyNerve growth factor links oral cancer progression, pain, and cachexia.Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patientsPrevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancerCytokine genetic variations and fatigue among patients with breast cancer.Pain and inflammation in women with early-stage breast cancer prior to induction of chemotherapy.Depressive symptoms among cancer patients in a Philippine tertiary hospital: prevalence, factors, and influence on health-related quality of lifeRole of inflammation gene polymorphisms on pain severity in lung cancer patients.Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genesSymptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genesFatigue in lung cancer patients: symptom burden and management of challengesCircadian disruption, fatigue, and anorexia clustering in advanced cancer patients: implications for innovative therapeutic approaches.Personality and the risk of cancer: a 16-year follow-up study of the GAZEL cohort.A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.Conducting Biobehavioral Research in Patients With Advanced Cancer: Recruitment Challenges and Solutions.What Makes You Feel Sick After Inflammation? Predictors of Acute and Persisting Physical Sickness Symptoms Induced by Experimental Endotoxemia.Association of KRAS gene mutations with depression in older metastatic colorectal cancer patients.Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer.Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications.Genetic polymorphism of tumor necrosis factor promoter region and susceptibility to develop Hodgkin lymphoma in a Mexican population.Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer.Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.
P2860
Q28397489-43FB44F0-D2AB-45A3-A232-E3C0535681CFQ28542574-F0DC315C-D101-46E0-86E6-040EDA8479DCQ30426453-4F423F58-3C47-486B-A317-9824976062D7Q33573675-E5869257-0FE2-41B6-9A4E-BE3443B9C3FCQ33643052-C9C593DB-EE53-4528-AB2B-44E9CE75C3C5Q33666335-7D33609D-B796-4401-AA85-BDE22CBDDEC6Q33806592-3BFD2AED-9EA4-4A28-B93C-6D7712B6D31AQ33839327-FCA93E5E-E673-4932-BB99-90C2F3E249EDQ34123648-890CDE2E-EBDA-48E3-A9E1-F286078C51D2Q34543971-4D25AE12-8F15-41ED-B22F-D63A254FB75CQ34920381-765B67E9-1AD2-441F-A6FC-C92343F272A5Q34988244-85698444-2146-4759-9389-4C20F2C99BD6Q35120883-66B649D7-7DD3-4712-AED5-81DA8848C8F3Q35178096-0032F6CC-06B9-4097-9EBE-FE2236AEA30FQ35565908-840DD7B6-3878-49C2-ACB9-7E7069BC951FQ35584773-349F1860-9106-45C5-BB24-828833464986Q35923297-38D91278-A177-4772-9370-A2C443F0E227Q35923511-698FC4B3-6BB0-4D6C-8DAF-B7E0B620C248Q35945680-056DB567-43A2-46DD-8CC6-E3E653832D63Q36031474-1F6B928C-2E2A-445B-9E3B-79B21136FAD0Q36625873-325BF80E-B9DF-40A0-ADB4-42F9C39D77B5Q36671163-22AD61A1-FB16-473D-A8B9-DE02D64E6992Q36793285-092427C2-4366-41FA-B237-DC46D4712012Q37058901-A87A13B9-8880-4FE1-A5AC-804E874A7C72Q37216443-E2BE495F-25F3-410C-B1BF-49D09B88CE74Q37382239-7E49A93C-0E6D-4025-90E1-E068830BBB9DQ37480694-2EF6757C-C6CA-4DF6-A2AA-63E283117D53Q37582383-9470CFAD-9EB0-4854-B537-261BFD5E6080Q37643536-5866D5B3-86AF-4E94-84AE-D87E99DF563FQ37668544-61533907-D2EC-4D03-81A9-664F70C95D35Q37687318-1D73CE79-036E-4A30-80FA-5EEE0140A68AQ37691482-2B8D3257-F6BD-430A-BF36-DCA239A9D146Q38785360-EF345BA5-67C7-4186-9162-2D7EF38D3FB9Q39027868-836A0F5F-257B-4A0F-814B-4BCED774B8FDQ39549412-6625ABDB-031C-4176-8678-840E7E81E655Q41030230-C161F625-7815-46DF-8489-F536C2C1423FQ41575072-66B1B4FF-69EB-4BC6-A672-76F22C008BE0Q42269975-F6C3DAE6-8440-4A53-8629-74F1F2A86C14Q44488675-40922C0E-FAF9-4FA7-809E-54F4252672ABQ52624073-8856E5C7-C67D-4BE8-9771-88CA3EEEF617
P2860
Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
@ast
Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
@en
type
label
Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
@ast
Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
@en
prefLabel
Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
@ast
Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
@en
P2093
P2860
P1433
P1476
Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
@en
P2093
Cielito C Reyes-Gibby
Margaret Spitz
Michael Fisch
Sanjay Shete
P2860
P304
P356
10.1016/S1470-2045(08)70197-9
P577
2008-08-01T00:00:00Z